Macquarie Group’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $715K | Hold |
110,000
| – | – | ﹤0.01% | 1423 |
|
|
2025
Q1 | $872K | Hold |
110,000
| – | – | ﹤0.01% | 1407 |
|
|
2024
Q4 | $1.39M | Hold |
110,000
| – | – | ﹤0.01% | 1289 |
|
|
2024
Q3 | $1.53M | Sell |
110,000
-603
| -0.5% | -$8.4K | ﹤0.01% | 1302 |
|
|
2024
Q2 | $1.52M | Buy |
110,603
+603
| +0.5% | +$8.31K | ﹤0.01% | 1295 |
|
|
2024
Q1 | $1.82M | Hold |
110,000
| – | – | ﹤0.01% | 1246 |
|
|
2023
Q4 | $1.61M | Hold |
110,000
| – | – | ﹤0.01% | 1285 |
|
|
2023
Q3 | $1.35M | Hold |
110,000
| – | – | ﹤0.01% | 1268 |
|
|
2023
Q2 | $1.31M | Hold |
110,000
| – | – | ﹤0.01% | 1299 |
|
|
2023
Q1 | $1.47M | Hold |
110,000
| – | – | ﹤0.01% | 1258 |
|
|
2022
Q4 | $2.37M | Hold |
110,000
| – | – | ﹤0.01% | 1162 |
|
|
2022
Q3 | $2.2M | Hold |
110,000
| – | – | ﹤0.01% | 1193 |
|
|
2022
Q2 | $1.97M | Buy |
+110,000
| New | +$1.97M | ﹤0.01% | 1300 |
|